Bound Therapeutics is a biotech company that utilizes a cancer cell-specific drug delivery system based on antisense oligonucleotides and targeting ligands, with a lead molecule in development for the treatment of triple negative breast cancer.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 229 Balfield Ter, Cherry Hill,nj 08003,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- boundtherapeutics.com
- Keywords
- Antisense oligonucleotides, Drug delivery, microRNA therapeutics, Machine learning, Drug discovery, Oncology, Artificial Intelligence, Targeting Ligands, Drug Delivery.
- HQ
- Cherry Hill, NJ
Bound Therapeutics Questions
Bound Therapeutics's website is boundtherapeutics.com
Bound Therapeutics's LinkedIn profile is https://www.linkedin.com/company/boundtherapeutics
Bound Therapeutics has
6 employees.
View email and phone details for 6
employees at Bound Therapeutics.
Bound Therapeutics's industry is
Biotechnology Research
Bound Therapeutics's top competitors are
Baruch Investment Management Group,
Hivebio.io,
Drs.linq,
Valfard Therapeutics,
Arcturian Analytics Corporation,
Cerespectus™,
Quneup®,
Ajaya Bio,
Higher Medicine,
Biolattice.
Bound Therapeutics's categories are Biotechnology Research
Bound Therapeutics's founding year is 2015
